<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Efficient esophageal clearance has an important defence role in the pathogenesis of the <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Many <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients have esophageal disturbances associated with or secondary to reflux, producing delayed clearance </plain></SENT>
<SENT sid="2" pm="."><plain>This delay exposes the esophageal mucosa to the reflux acid content </plain></SENT>
<SENT sid="3" pm="."><plain>To determine esophageal transit we scanned the esophageal transit of a 15 ml bolus containing colloidal 300/cCi 99m Tc </plain></SENT>
<SENT sid="4" pm="."><plain>The esophageal transit was calculated in seconds according to formula E.T. = T 1/2 x 5 </plain></SENT>
<SENT sid="5" pm="."><plain>The study included 74 GERD patients </plain></SENT>
<SENT sid="6" pm="."><plain>The following investigations were carried out in <z:hpo ids='HP_0000001'>all</z:hpo> the cases: esophageal X-ray, GER scintigram, endoscopy, esophageal biopsy, Bernstein test and esophageal transit scintigram </plain></SENT>
<SENT sid="7" pm="."><plain>Endoscopy revealed lesions of the esophagus (of 1st, 2nd and 3rd degree) in 39 patients, <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett syndrome</z:e> in 8 cases and <z:mpath ids='MPATH_458'>normal</z:mpath> in 27 </plain></SENT>
<SENT sid="8" pm="."><plain>Esophageal transit scanning was <z:mpath ids='MPATH_458'>normal</z:mpath> in 18 cases (24%), and prolonged in 56 cases (76%) </plain></SENT>
<SENT sid="9" pm="."><plain>Only 7 (39%) of the 18 patients with a <z:mpath ids='MPATH_458'>normal</z:mpath> transit presented lesions of the mucosa, the latter being more frequent in patients with a prolonged transit, i.e. 40 of 56 patients (71.5%) </plain></SENT>
<SENT sid="10" pm="."><plain>The mean value of the transit in different degrees of <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (I, II, III) and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett syndrome</z:e> were: 12.73 +/- 5.36; 13.30 +/- 7.90; 10.35 +/- 5.78; 17.25 +/- 11.17 </plain></SENT>
<SENT sid="11" pm="."><plain>In conclusion esophageal transit scanning is a useful test in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> patients as it has a prognostic value </plain></SENT>
<SENT sid="12" pm="."><plain>A prolonged esophageal transit is frequently associated with lesions, the more severe the slower is the transit </plain></SENT>
<SENT sid="13" pm="."><plain>Moreover the test may indicate certain drugs acting upon the esophageal motor disturbances </plain></SENT>
</text></document>